BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3040819)

  • 41. Assay of calmodulin by Ca2+-dependent phosphodiesterase.
    Wallace RW; Tallant EA; Cheung WY
    Methods Enzymol; 1983; 102():39-47. PubMed ID: 6316081
    [No Abstract]   [Full Text] [Related]  

  • 42. Functional properties of covalent beta-endorphin peptide/calmodulin complexes. Chlorpromazine binding and phosphodiesterase activation.
    Giedroc DP; Keravis TM; Staros JV; Ling N; Wells JN; Puett D
    Biochemistry; 1985 Feb; 24(5):1203-11. PubMed ID: 3006746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanism of activation of cyclic nucleotide phosphodiesterase: requirement of the binding of four Ca2+ to calmodulin for activation.
    Huang CY; Chau V; Chock PB; Wang JH; Sharma RK
    Proc Natl Acad Sci U S A; 1981 Feb; 78(2):871-4. PubMed ID: 6262778
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.
    Kakiuchi S; Yamazaki R; Teshima Y; Uenishi K; Miyamoto E
    Biochem J; 1975 Jan; 146(1):109-20. PubMed ID: 167710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The binding of cyclic AMP to renal brush border membranes.
    Insel P; Balakir R; Sacktor B
    J Cyclic Nucleotide Res; 1975; 1(2):107-22. PubMed ID: 177456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of calmodulin with iodothyronines: effect of iodothyronines on the calmodulin activation of cyclic AMP phosphodiesterase.
    Rao GS; Lemoch H; Cronrath C
    Mol Cell Endocrinol; 1987 Sep; 53(1-2):45-52. PubMed ID: 2822507
    [TBL] [Abstract][Full Text] [Related]  

  • 47. On the mechanism of activation of cyclic mucleotide phosphodiesterase by calmodulin.
    Wang JH; Sharma RK; Huang CY; Chau V; Chock PB
    Ann N Y Acad Sci; 1980; 356():190-204. PubMed ID: 6263147
    [No Abstract]   [Full Text] [Related]  

  • 48. Cyclic nucleotide phosphodiesterase activity in bovine brain coated vesicles.
    Silva WI; Schook W; Mittag TW; Puszkin S
    J Neurochem; 1986 Apr; 46(4):1263-71. PubMed ID: 2869110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The involvement of a calmodulin-dependent phosphodiesterase in the negative control of carbamylcholine on cyclic AMP levels in dog thyroid slices.
    Miot F; Dumont JE; Erneux C
    FEBS Lett; 1983 Jan; 151(2):273-6. PubMed ID: 6187601
    [No Abstract]   [Full Text] [Related]  

  • 50. Insulin-dependent and insulin-independent low Km cyclic AMP phosphodiesterase from rat adipose tissue.
    Weber HW; Appleman MM
    J Biol Chem; 1982 May; 257(10):5339-41. PubMed ID: 6279596
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphorylation and activation of calmodulin-sensitive cyclic nucleotide phosphodiesterase by a brain Ca2+, calmodulin-dependent protein kinase.
    Fukunaga K; Yamamoto H; Tanaka E; Iwasa T; Miyamoto E
    Life Sci; 1984 Jul; 35(5):493-9. PubMed ID: 6087066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cyclic nucleotide phosphodiesterase of buffalo spermatozoa with sperm chromatin.
    Bhatnagar SK; Anand SR
    Biochim Biophys Acta; 1981 May; 674(2):212-24. PubMed ID: 6263350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Purification and properties of calmodulin-stimulated phosphodiesterase from mammalian brain.
    Kincaid RL; Manganiello VC; Odya CE; Osborne JC; Stith-Coleman IE; Danello MA; Vaughan M
    J Biol Chem; 1984 Apr; 259(8):5158-66. PubMed ID: 6325422
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase.
    Lam HY
    Biochem Biophys Res Commun; 1984 Jan; 118(1):27-32. PubMed ID: 6320825
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of psychotropic preparations on cyclic AMP phosphodiesterase activity in the rat cerebral cortex].
    Shchekoldina TG; Vatolkina OE; Libinzon RE
    Vopr Med Khim; 1978; 24(2):166-9. PubMed ID: 208286
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs).
    Juilfs DM; Soderling S; Burns F; Beavo JA
    Rev Physiol Biochem Pharmacol; 1999; 135():67-104. PubMed ID: 9932481
    [No Abstract]   [Full Text] [Related]  

  • 57. The differential stimulation of brain and heart cyclic-AMP phosphodiesterase by oncomodulin.
    Mutus B; Karuppiah N; Sharma RK; MacManus JP
    Biochem Biophys Res Commun; 1985 Aug; 131(1):500-6. PubMed ID: 2994666
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Calcium- and calmodulin-independent modulation of calmodulin-sensitive hypothalamic cyclic nucleotide phosphodiesterase activity by the (11-19) fragment of thymosin beta 4.
    Galoyan AA; Abrahamian GE; Chailyan SG; Hashim GA; Lajtha A
    Neurochem Res; 1994 Apr; 19(4):451-6. PubMed ID: 8065501
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calmodulin in porcine malignant hyperpyrexia.
    Collins SP; White MD; Denborough MA
    Int J Biochem; 1987; 19(1):63-70. PubMed ID: 3032704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclic 3':5'-nucleotide phosphodiesterase of rabbit sinoatrial node.
    Taniguchi T; Fujiwara M; Lee JJ; Hidaka H
    Biochim Biophys Acta; 1978 Feb; 522(2):465-76. PubMed ID: 203321
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.